Pancreatic Cancer Research

ResearcherKeio UniversityActive in the last 2 years

Akiyoshi Hirayama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0440-6820; OpenAlex author ID A5046623627. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer. Co-author DOI 10.1016/j.isci.2026.117071↗
  2. Metabolomic Analysis of Small Extracellular Vesicles Derived from Pancreatic Cancer Cells Cultured under Normoxia and Hypoxia. Last author DOI 10.3390/metabo11040215↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Sano · 1 shared paper, 2026 · strength 0.24
  2. Koji Miyabayashi · 1 shared paper, 2026 · strength 0.24
  3. Yohei Masugi · 1 shared paper, 2026 · strength 0.24
  4. Yoshimi Ichimaru · 1 shared paper, 2026 · strength 0.24
  5. Gen Kimura · 1 shared paper, 2026 · strength 0.24
  6. Hideaki Ijichi · 1 shared paper, 2026 · strength 0.24
  7. Atsushi Masamune · 1 shared paper, 2026 · strength 0.24
  8. Mitsuhiro Fujishiro · 1 shared paper, 2026 · strength 0.24
  9. Ryosuke Hayasaka · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.